SUBMISSION OF SUGGESTED RETAIL PRICE OF PHARMACEUTICAL PRODUCT AS ADDITIONAL REQUIREMENT FOR PRODUCT REGISTRATION
other things that, “It is policy of the state to ensure the availability
of basic necessities and prime commodities at reasonable prices at all times x x x “.
For the proper implementation of the above policy, with respect to
pharmaceutical products, and consistent with the provisions of R.A. 7394
the “Consumer Act” and R.A. 3720 the Foods, Drugs, Devices and
Cosmetics Act”, the Bureau of Food and Drugs is hereby ordered to
require the submission of a declaration of the “suggested retail price”
of pharmaceutical products by the registrant as an additional
requirement for product registration, an addendum to Administrative
Order 67, s. 1989 “Subject: Requirements for Registration of Pharmaceutical Products”.
For purposes of this Administrative Order, Suggested Retail Price is
defined as the proposed amount or cost of a pharmaceutical product per
unit item when retailer offers this for sale to the consumer or
end-user. Furthermore, unit item refers to per tablet or capsule, per
ampoule or vial, or per bottle of a liquid formulation, as purchased in a
local drug outlet by the consumer.
This Order shall take effect fifteen (15) days after its publication in a newspaper of general circulation.
Adopted: 21 Nov. 1999
(SGD.) ALBERTO G. ROMUALDEZ, JR. MD.
Secretary of Health